Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. scores highest on Torque (96) and lowest on Price (0). Its PosiPenta is 47.41 out of 100, around the middle of similar companies.
On the Penta Grid this week, Aquestive Therapeutics, Inc. is Grid #327 of 837 in the Healthcare sector in United States, and Grid #2,170 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | 47.41 | 0 | 44 | 47 | 96 | 50 |
| Faeth Therapeutics, Inc. | 39.30 | 23 | 39 | 50 | 48 | 37 |
| Bright Minds Biosciences Inc. | 43.95 | 26 | 18 | 34 | 76 | 66 |
| Delcath Systems, Inc. | 63.00 | 17 | 85 | 81 | 72 | 60 |
| AngioDynamics, Inc. | 55.33 | 23 | 63 | 63 | 61 | 66 |
| CytomX Therapeutics, Inc. | 38.50 | 32 | 44 | 22 | 63 | 31 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.73 |
| P/B ratio | -8.38 |
EEarnings
| Trailing EPS | ₹-62.51 |
| Forward EPS | ₹-53.99 |
NNitro
| Price | 358.02 |
| 52-week high | 715.10 |
| 52-week low | 277.51 |
| Fall from 52-week high | 49.9% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.26 |
AAnchor
| Beta (price swings) | 1.49 |
| Market cap | ₹4,493 Cr |
| Insider holding | 10.76% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Aquestive Therapeutics, Inc.'s PosiPenta score?
Aquestive Therapeutics, Inc.'s PosiPenta is 47.41 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Aquestive Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Aquestive Therapeutics, Inc. is Grid #327 of 837 in the Healthcare sector in United States, and Grid #2,170 of 4,000 in United States.
Which PosiPenta pillar is strongest for Aquestive Therapeutics, Inc.?
Torque (durability), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Aquestive Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Aquestive Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it fell 0.09 points, from 47.50 to 47.41.
PositoAI is for research and education only and is not investment advice.